Revolutionary Innovations in Diabetes Research: From Biomarkers to Genomic Medicine
Journal Title: Iranian journal of diabetes and obesity (IJDO) - Year 2023, Vol 15, Issue 4
Abstract
Diabetes mellitus is a chronic metabolic disease characterized by hyperglycemia resulting from inadequate insulin signaling. Current management relies on biomarkers such as hemoglobin A1c (HbA1c) to guide therapy, but emerging tools offer opportunities to transform care through more personalized approaches. Molecular biomarkers, including microRNAs, metabolites, and proteins, may enable better prediction of disease course and risk of complications in individuals. Genomic medicine leverages knowledge of genetic architecture to guide tailored prevention and treatment based on an individual’s genomic profile. Stem cell research differentiates functional insulin-secreting cells for transplantation into patients as an alternative to exogenous insulin. Gene silencing techniques such as RNA interference can restore defective insulin production and secretion pathways by inhibiting dysregulated gene expression. Artificial intelligence applications automate glucose monitoring, insulin delivery, diagnostic screening for complications, and digital health coaching. Despite barriers to translation, these technologies have disruptive potential for predictive, preventive, precise, and participatory care paradigms in diabetes management. Continued research on molecular biomarkers, pharmacogenomics, stem cell therapies, gene editing, and artificial intelligence (AI) aims to improve patient outcomes through more personalized approaches tailored to the specific biological vulnerabilities underlying each individual’s diabetes.
Authors and Affiliations
Tamer Addissouky,Majeed Ali,Ibrahim El Tantawy El Sayed,Yuliang Wang,
Keywords
Related Articles
- EP ID EP726742
- DOI -
- Views 43
- Downloads 0
Epidemilogic Study of Death Caused by Endocrine, Nutritional, and Metabolic Diseases in Iran During 2006-2018
Objective: The epidemiological transition and the increase of chronic diseases resulted in the rise of endocrine, nutritional and metabolic (ENM) diseases as causes of death. This study aimed to explore the death rate ca...
Correlation between Cytochrome P450, 5-alpha Reductase, and Androgen Receptor Levels in Patients with Type 2 Diabetes Mellitus
Objective: Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases. The CYP450 plays an important role in the biosynthesis of steroid hormones and the hormonal activity is mediated by the androgen rece...
Exploring Natural Products to Control Type 2 Diabetes Mellitus through Targeting Advanced Glycation End Products
Cardiovascular disease (CVD) and diabetes mellitus (DM) are the pressing global health issue, with advanced glycation end products (AGEs) playing a crucial role in its development. AGEs are harmful compounds formed throu...
Relationship between Changes in Serum Insulin with Hepatic Expression of PEPCK, G6Pase and HNF4α in Response to Resistance Training in Diabetic Rats with High-Fat Diet and STZ
Objective: Genetic studies indicate that available insulin influences the activity or expression of hepatic gluconeogenic genes. This study aimed to assess the effect of resistance exercise program on gluconeogenic genes...
Genes Predisposing to Monogenic, Polygenic, and Syndromic Obesity: A Review of Current Trends and Prospects for Standard Obesity Genetic Testing
Objective: The burden of obesity is currently enormous, necessitating a novel strategy to complement the existing ones. Accordingly, genetic predisposition is suspected in many cases of the disease, which can potentially...